BlackRock’s Catheter Precision VTAK Stock Holding History
Bought
Maintained
Sold
Other funds holding VTAK
WAM
AC
VF
HF
TRCT
HI
FDCDDQ
APC
BlackRock's VTAK Position: Q3 2024 in Review
BlackRock sold out of Catheter Precision (VTAK) in Q3 2024, closing a stake of 97 shares — an estimated $10.8K sold.
BlackRock first reported a position in VTAK in Q4 2022 and held it in 7 quarters. The position peaked at $109K in Q4 2022. 9 funds tracked by Wall St. Rank hold VTAK as of Q3 2024.
- BlackRock reported no remaining Catheter Precision position as of Q3 2024 after selling out during the quarter.
- BlackRock sold 97 Catheter Precision shares in Q3 2024, an estimated $10.8K.
- BlackRock first reported a position in Catheter Precision in Q4 2022 and held it in 7 quarters.
- BlackRock's Catheter Precision position peaked at $109K in Q4 2022.
- 9 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2024.
Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.